The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment
Nicole L Allard, Jennifer H MacLachlan, Benjamin C Cowie
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH | WILEY | Published : 2015
OBJECTIVE: To estimate the level of access to diagnosis, management and treatment for people living with chronic hepatitis B (CHB) in Australia, and to identify the gaps in clinical care for people living with CHB. METHODS: Analysis of publicly available population level data including infectious disease notifications, Medicare and Pharmaceutical Benefits Scheme utilisation data, census-based estimates of CHB prevalence and burden, and mathematical modelling. RESULTS: In 2012, of the estimated 218,567 Australians living with CHB, 57% had been diagnosed, 17,367 people (8%) received recommended HBV DNA viral load testing (without treatment) and 10,987 (5%) received antiviral therapy. CONCLUSIO..View full abstract
This work was supported through the Communicable Diseases Flexible Fund Grant from the Australian Government Department of Health and Ageing to the Australasian Society for HIV Medicine, and the Victorian Infectious Diseases Reference Laboratory. NA is supported by an Australian Postgraduate Award through the University of Melbourne.